General Information of Drug Transporter (DT)
DT ID DTD0497 Transporter Info
Gene Name SLC9C1
Transporter Name Sodium/hydrogen exchanger 10
Gene ID
285335
UniProt ID
Q4G0N8
Post-Translational Modification of This DT
Overview of SLC9C1 Modification Sites with Functional and Structural Information
Sequence
PTM type
X-N-glycosylation X-Phosphorylation X: Amino Acid

N-glycosylation

  Asparagine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC9C1 [1]

Role of PTM

Potential impacts

Modified Residue

Asparagine

Modified Location

278

Experimental Method

Co-Immunoprecipitation

Detailed Description

N-linked Glycosylation at SLC9C1 Asparagine 278 has the potential to affect its expression or activity.

Phosphorylation

  Serine

          6 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC9C1 [2] , [3]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

349

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC9C1 Serine 349 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC9C1 [4] , [5]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

526

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC9C1 Serine 526 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC9C1 [4]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

537

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC9C1 Serine 537 has the potential to affect its expression or activity.

  PTM Phenomenon 4

Have the potential to influence SLC9C1 [2]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

832

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC9C1 Serine 832 has the potential to affect its expression or activity.

  PTM Phenomenon 5

Have the potential to influence SLC9C1 [6]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

853

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC9C1 Serine 853 has the potential to affect its expression or activity.

  PTM Phenomenon 6

Have the potential to influence SLC9C1 [2]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

855

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC9C1 Serine 855 has the potential to affect its expression or activity.

  Threonine

          2 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC9C1 [6]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

861

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC9C1 Threonine 861 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC9C1 [4]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

1159

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC9C1 Threonine 1159 has the potential to affect its expression or activity.

  Tyrosine

          2 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC9C1 [4]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

531

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC9C1 Tyrosine 531 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC9C1 [7]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

878

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC9C1 Tyrosine 878 has the potential to affect its expression or activity.
References
1 dbPTM in 2022: an updated database for exploring regulatory networks and functional associations of protein post-translational modifications. Nucleic Acids Res. 2022 Jan 7;50(D1):D471-D479. (ID: SL9C1_HUMAN)
2 Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Mol Cell Proteomics. 2014 Jul;13(7):1690-704.
3 Reactive Oxygen Species (ROS)-Activated ATM-Dependent Phosphorylation of Cytoplasmic Substrates Identified by Large-Scale Phosphoproteomics Screen. Mol Cell Proteomics. 2016 Mar;15(3):1032-47.
4 iTRAQ labeling is superior to mTRAQ for quantitative global proteomics and phosphoproteomics. Mol Cell Proteomics. 2012 Jun;11(6):M111.014423.
5 Quantitative phosphoproteomic analysis of acquired cancer drug resistance to pazopanib and dasatinib. J Proteomics. 2018 Jan 6;170:130-140.
6 Improve the coverage for the analysis of phosphoproteome of HeLa cells by a tandem digestion approach. J Proteome Res. 2012 May 4;11(5):2828-37.
7 Tip-Based Fractionation of Batch-Enriched Phosphopeptides Facilitates Easy and Robust Phosphoproteome Analysis. J Proteome Res. 2018 Jan 5;17(1):46-54.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.